Oxaliplatin and 5-Fluorouracil With or Without Docetaxel in Elderly Patients (>65 y) With Stomach and Esophagus Cancer
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
In this trial, FLOT will be evaluated as therapy option for elderly patients (>65 years) with
advanced gastric cancer in comparison to the well established FLO scheme. The hypothesis is
that FLOT is more effective than FLO in elderly patients with acceptable side effects.